PTEN (Concentrate)
The PTEN protein is a lipid phosphatase with tumor-suppressing abilities. Results aid in the classification of a variety of malignancies, including breast (1), prostate (2) and endometrial cancer.
- Monoclonal Mouse Anti-Human
No data to display
This product is not available for purchase by the general public.
Product Details
Features
- Excellent specificity
- High lot to lot consistency
- Optimized for immunohistochemistry (IHC) with validated protocols
- Certified manufacturing facilities guarantee full quality control
- More than 50 years experience ensuring quality and innovation in antibodies and reagents
Specifications
Application |
|
Clone |
|
Code Number |
|
Immunogen |
|
Isotype |
|
Reagent Provided |
|
Solutions |
|
Species |
|
Specificity |
|
Literature
- Technical Overviews
-
Immunohistochemical Staining Methods - Education Guide, Sixth Edition
The focus of the sixth edition of the IHC Guidebook is to provide a comprehensive immunohistochemistry (IHC) resource for lab managers, lab technicians, learning pathologists, and students from around the world.
- Technical Overviews
- English
- 30 Nov 2021
- 27.05 MB
Support
- Instructions for Use
-
Featured References
- Product Description References
-
1. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999,155:1253-60.
2. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 1999,59:4291-6.
Promotions